Literature DB >> 29985266

Availability of HIV and HCV On-Site Testing and Treatment at Syringe Service Programs in the United States.

Czarina N Behrends1, Ann V Nugent2, Don C Des Jarlais2, Jemima A Frimpong3, David C Perlman2, Bruce R Schackman1.   

Abstract

Entities:  

Mesh：

Year:  2018        PMID： 29985266      PMCID： PMC6347107          DOI： 10.1097/QAI.0000000000001792

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr        ISSN： 1525-4135            Impact factor:   3.731


× No keyword cloud information.
  19 in total

1.  Stigma, discrimination and the health of illicit drug users.

Authors:  Jennifer Ahern; Jennifer Stuber; Sandro Galea
Journal:  Drug Alcohol Depend       Date:  2006-11-21       Impact factor: 4.492

2.  Unmet need for recommended preventive health services among clients of California syringe exchange programs: implications for quality improvement.

Authors:  K G Heinzerling; A H Kral; N M Flynn; R L Anderson; A Scott; M L Gilbert; S M Asch; R N Bluthenthal
Journal:  Drug Alcohol Depend       Date:  2005-07-25       Impact factor: 4.492

3.  Syringe Service Programs for Persons Who Inject Drugs in Urban, Suburban, and Rural Areas - United States, 2013.

Authors:  Don C Des Jarlais; Ann Nugent; Alisa Solberg; Jonathan Feelemyer; Jonathan Mermin; Deborah Holtzman
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2015-12-11       Impact factor: 17.586

4.  Vital Signs: Trends in HIV Diagnoses, Risk Behaviors, and Prevention Among Persons Who Inject Drugs - United States.

Authors:  Cyprian Wejnert; Kristen L Hess; H Irene Hall; Michelle Van Handel; Demorah Hayes; Paul Fulton; Qian An; Linda J Koenig; Joseph Prejean; Linda A Valleroy
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2016-12-02       Impact factor: 17.586

5.  An institutional analysis of HIV prevention efforts by the nation's outpatient drug abuse treatment units.

Authors:  T D'Aunno; T E Vaughn; P McElroy
Journal:  J Health Soc Behav       Date:  1999-06

6.  Perceived discrimination among racial and ethnic minority drug users and the association with health care utilization.

Authors:  Courtney McKnight; Martha Shumway; Carmen L Masson; Enrique R Pouget; Ashly E Jordan; Don C Des Jarlais; James L Sorensen; David C Perlman
Journal:  J Ethn Subst Abuse       Date:  2017-03-17       Impact factor: 1.507

7.  HIV infection and risk, prevention, and testing behaviors among injecting drug users -- National HIV Behavioral Surveillance System, 20 U.S. cities, 2009.

Authors:  Dita Broz; Cyprian Wejnert; Huong T Pham; Elizabeth DiNenno; James D Heffelfinger; Melissa Cribbin; Nevin Krishna; Eyasu H Teshale; Gabriela Paz-Bailey
Journal:  MMWR Surveill Summ       Date:  2014-07-04

8.  Rising Mortality Associated With Hepatitis C Virus in the United States, 2003-2013.

Authors:  Kathleen N Ly; Elizabeth M Hughes; Ruth B Jiles; Scott D Holmberg
Journal:  Clin Infect Dis       Date:  2016-03-01       Impact factor: 9.079

9.  Consistent Estimates of Very Low HIV Incidence Among People Who Inject Drugs: New York City, 2005-2014.

Authors:  Don C Des Jarlais; Kamyar Arasteh; Courtney McKnight; Jonathan Feelemyer; Aimée N C Campbell; Susan Tross; Lou Smith; Hannah L F Cooper; Holly Hagan; David Perlman
Journal:  Am J Public Health       Date:  2016-01-21       Impact factor: 9.308

10.  Community Outbreak of HIV Infection Linked to Injection Drug Use of Oxymorphone--Indiana, 2015.

Authors:  Caitlin Conrad; Heather M Bradley; Dita Broz; Swamy Buddha; Erika L Chapman; Romeo R Galang; Daniel Hillman; John Hon; Karen W Hoover; Monita R Patel; Andrea Perez; Philip J Peters; Pam Pontones; Jeremy C Roseberry; Michelle Sandoval; Jessica Shields; Jennifer Walthall; Dorothy Waterhouse; Paul J Weidle; Hsiu Wu; Joan M Duwve
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2015-05-01       Impact factor: 17.586
View more
  8 in total

1.  Contact tracing for hepatitis C: The case for novel screening strategies as we strive for viral elimination.

Authors:  Caroline Katzman; Pedro Mateu-Gelabert; Shashi N Kapadia; Benjamin J Eckhardt
Journal:  Int J Drug Policy       Date:  2019-04-19

2.  Participants of a mail delivery syringe services program are underserved by other safe sources for sterile injection supplies.

Authors:  Benjamin T Hayes; Jamie Favaro; Dan Coello; Czarina N Behrends; Andrea Jakubowski; Aaron D Fox
Journal:  Int J Drug Policy       Date:  2021-10-05

Review 3.  Harm Reduction Services to Prevent and Treat Infectious Diseases in People Who Use Drugs.

Authors:  Kinna Thakarar; Katherine Nenninger; Wollelaw Agmas
Journal:  Infect Dis Clin North Am       Date:  2020-09       Impact factor: 5.982

4.  Implementation and first-year operating costs of an academic medical center-based syringe services program.

Authors:  Tyler S Bartholomew; Hardik Patel; Kathryn McCollister; Daniel J Feaster; Hansel E Tookes
Journal:  Harm Reduct J       Date:  2021-11-19

5.  When Perfect Is the Enemy of Tested: a Call to Scale Rapid HIV Testing for People Who Inject Drugs.

Authors:  Justin Alves; Jessica Stewart; Glorimar Ruiz-Mercado; Jessica L Taylor
Journal:  J Gen Intern Med       Date:  2022-02-07       Impact factor: 6.473

6.  Service utilization patterns and characteristics among clients of integrated supervised consumption sites in Toronto, Canada.

Authors:  Tanner Nassau; Gillian Kolla; Kate Mason; Shaun Hopkins; Paula Tookey; Elizabeth McLean; Dan Werb; Ayden Scheim
Journal:  Harm Reduct J       Date:  2022-03-29

7.  The Impact of COVID-19 on Syringe Services Programs in the United States.

Authors:  Sara N Glick; Stephanie M Prohaska; Paul A LaKosky; Alexa M Juarez; Maria A Corcorran; Don C Des Jarlais
Journal:  AIDS Behav       Date:  2020-09

8.  Impact of routine opt-out HIV/HCV screening on testing uptake at a syringe services program: An interrupted time series analysis.

Authors:  Tyler S Bartholomew; Hansel E Tookes; David P Serota; Czarina N Behrends; David W Forrest; Daniel J Feaster
Journal:  Int J Drug Policy       Date:  2020-07-27
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.